A product intended for use in the diagnosis of disease and which is an in vitro diagnostic product as defined in Sec. 809.3(a) of this chapter shall be deemed to be in compliance with the requirements of this part and section 502(f)(1) of the Federal Food, Drug, and Cosmetic Act if it meets the requirements of subpart B of this part and the requirements of Sec. 809.10 of this chapter. [78 FR 55820, Sept. 24, 2013]